Light-responsive nanoparticle depot to control release of a small molecule angiogenesis inhibitor in the posterior segment of the eye
Open accessThe DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Therapies for macular degeneration and diabetic retinopathy require intravitreal injections every 4-8 weeks. Injections are uncomfortable, time-consuming, and carry risks of infection and retinal damage. However, drug delivery via noninvasive methods to the posterior segment of the eye has been a major challenge due to the eye's unique anatomy and physiology. Here we present a novel nanoparticle depot platform for on-demand drug delivery using a far ultraviolet (UV) light-degradable polymer, which allows noninvasively triggered drug release using brief, low-power light exposure. Nanoparticles stably retain encapsulated molecules in the vitreous, and can release cargo in response to UV exposure up to 30 weeks post-injection. Light-triggered release of nintedanib (BIBF 1120), a small molecule angiogenesis inhibitor, 10 weeks post-injection suppresses choroidal neovascularization (CNV) in rats. Light-sensitive nanoparticles are biocompatible and cause no adverse effects on the eye as assessed by electroretinograms (ERG), corneal and retinal tomography, and histology.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
BIBF 1120: Triple Angiokinase Inhibitor with Sustained Receptor Blockade and Good Antitumor Efficacy
Hilberg, F., Roth, G. J., Krssak, M., Kautschitsch, S., Sommergruber, W., Tontsch-Grunt, U., Garin-Chesa, P., Bader, G., Zoephel, A., Quant, J., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6307 · Cited by 1,056
Acute effects of UVR on human eyes and skin
Young, A. R. (2006) · Progress in Biophysics and Molecular Biology · doi:10.1016/j.pbiomolbio.2006.02.005 · Cited by 267
Cited by
Photoresponsive biomaterials for targeted drug delivery and 4D cell culture
Ruskowitz, E. R., & DeForest, C. A. (2018) · Nature Reviews Materials · doi:10.1038/natrevmats.2017.87 · Cited by 398
Remote Light‐Responsive Nanocarriers for Controlled Drug Delivery: Advances and Perspectives
Zhao, W., Zhao, Y., Wang, Q., Liu, T., Sun, J., & Zhang, R. (2019) · Small · doi:10.1002/smll.201903060 · Cited by 329
Deng, S., Gigliobianco, M. R., Censi, R., & Di Martino, P. (2020) · Nanomaterials · doi:10.3390/nano10050847 · Cited by 329
Han, H., Li, S., Xu, M., Zhong, Y., Fan, W., Xu, J., Zhou, T., Ji, J., Ye, J., & Yao, K. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.114770 · Cited by 322
Recent advances in stimuli-responsive polymer systems for remotely controlled drug release
Zhang, A., Jung, K., Li, A., Liu, J., & Boyer, C. (2019) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2019.101164 · Cited by 268
Metadata
- Authors
- Huu, V. A. N., Luo, J., Zhu, J., Zhu, J., Patel, S., Boone, A., Mahmoud, E., McFearin, C., Olejniczak, J., de Gracia Lux, C., Lux, J., Fomina, N., Huynh, M., Zhang, K., & Almutairi, A.
- Venue
- Journal of Controlled Release
- Publisher
- Elsevier BV
- Published
- 2015-02
- Volume
- 200
- Pages
- 71-77
- ISSN
- 0168-3659 (ISSN-L)
- OpenAlex
- W1982299249
- Cited by
- 122
- References
- 2
- FWCI
- 6.56
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Light-responsive nanoparticle depot to control release of a small molecule angiogenesis inhibitor in the posterior segment of the eye. https://app.cochat.ai/papers/10.1016/j.jconrel.2015.01.001
- The paper
- Huu, V. A. N., Luo, J., Zhu, J., Zhu, J., Patel, S., Boone, A., Mahmoud, E., McFearin, C., Olejniczak, J., de Gracia Lux, C., Lux, J., Fomina, N., Huynh, M., Zhang, K., & Almutairi, A. (2015). Light-responsive nanoparticle depot to control release of a small molecule angiogenesis inhibitor in the posterior segment of the eye. Journal of Controlled Release. https://doi.org/10.1016/j.jconrel.2015.01.001
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.